EMG
EW icon

ETF Managers Group’s Edwards Lifesciences EW Stock Holding History

ETF Managers Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$507K Buy
6,131
+91
+2% +$7.15K 0.02% 450
2022
Q4 		$451K Buy
6,040
+220
+4% +$17K 0.02% 383
2022
Q3 		$481K Buy
5,820
+225
+4% +$21.6K 0.02% 438
2022
Q2 		$537K Sell
5,595
-2,714
-33% -$281K 0.02% 428
2022
Q1 		$973K Buy
8,309
+142
+2% +$15.9K 0.02% 284
2021
Q4 		$1.07M Buy
8,167
+387
+5% +$45.1K 0.02% 277
2021
Q3 		$883K Buy
7,780
+597
+8% +$68.1K 0.02% 293
2021
Q2 		$744K Buy
7,183
+2,076
+41% +$196K 0.01% 308
2021
Q1 		$423K Buy
5,107
+686
+16% +$58K 0.01% 520
2020
Q4 		$396K Buy
4,421
+392
+10% +$32.5K 0.01% 448
2020
Q3 		$316K Buy
4,029
+198
+5% +$15.4K 0.01% 452
2020
Q2 		$260K Sell
3,831
-615
-14% -$43.7K 0.01% 494
2020
Q1 		$291K Buy
4,446
+456
+11% +$32.9K 0.01% 318
2019
Q4 		$309K Sell
3,990
-6,507
-62% -$508K 0.01% 357
2019
Q3 		$760K Sell
10,497
-3,213
-23% -$226K 0.03% 220
2019
Q2 		$847K Sell
13,710
-7,173
-34% -$434K 0.03% 203
2019
Q1 		$1.33M Sell
20,883
-9,300
-31% -$531K 0.07% 140
2018
Q4 		$1.54M Buy
30,183
+27,786
+1,159% +$1.41M 0.07% 145
2018
Q3 		$139K Sell
2,397
-15,417
-87% -$754K 0.01% 312
2018
Q2 		$2.35M Buy
17,814
+15,582
+698% +$727K 0.17% 77
2018
Q1 		$101K Buy
2,232
+276
+14% +$12K 0.01% 278
2017
Q4 		$73K Buy
1,956
+276
+16% +$10.1K 0.01% 352
2017
Q3 		$61K Buy
1,680
+150
+10% +$5.72K 0.01% 242
2017
Q2 		$112K Buy
+1,530
New +$55.8K 0.01% 169
2016
Q4 		$18K Sell
600
-390
-39% -$12.6K 0.08% 56
2016
Q3 		$39K Buy
+990
New +$37.3K 0.08% 50
2016
Q1 		$54K Buy
+1,737
New +$47.9K 0.04% 120

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

ETF Managers Group's EW Position: Q1 2023 in Review

ETF Managers Group increased its Edwards Lifesciences (EW) stake by 1.5% in Q1 2023, buying an estimated $7.15K and bringing the position to 6,131 shares worth $507K. The position accounts for 0.02% of the portfolio, ranked #450.

ETF Managers Group first reported a position in EW in Q1 2016 and has held it in 27 quarters since. The position peaked at $2.35M in Q2 2018. 1,246 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • ETF Managers Group held 6,131 shares of Edwards Lifesciences worth $507K as of Q1 2023.
  • ETF Managers Group bought 91 Edwards Lifesciences shares in Q1 2023, an estimated $7.15K.
  • Edwards Lifesciences made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #450 holding.
  • ETF Managers Group first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 27 quarters since.
  • ETF Managers Group's Edwards Lifesciences position peaked at $2.35M in Q2 2018.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.